New York State Common Retirement Fund Protagonist Therapeutics, Inc Transaction History
New York State Common Retirement Fund
- $68.1 Billion
- Q1 2025
A detailed history of New York State Common Retirement Fund transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 19,582 shares of PTGX stock, worth $867,090. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,582
Previous 17,882
9.51%
Holding current value
$867,090
Previous $690,000
37.25%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding PTGX
# of Institutions
259Shares Held
56.2MCall Options Held
226KPut Options Held
218K-
Farallon Capital Management LLC San Francisco, CA5.93MShares$263 Million1.22% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$255 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.5MShares$243 Million3.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$187 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$147 Million0.01% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.17B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...